Stay updated on Pembrolizumab+Ferumoxytol MRI in NSCLC Brain Metastases Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab+Ferumoxytol MRI in NSCLC Brain Metastases Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab+Ferumoxytol MRI in NSCLC Brain Metastases Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    The website has been updated from version 2.14.0 to 2.14.1.
    Difference
    0.1%
    Check dated 2025-01-20T01:48:45.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The website has updated the 'type of intervention' feature from version 2.13.3 to 2.14.0, indicating a significant change in this functionality.
    Difference
    0.2%
    Check dated 2025-01-12T22:27:40.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    No Change Detected
  5. Check
    29 days ago
    No Change Detected
  6. Check
    37 days ago
    Change Detected
    Summary
    The website has been updated from version 2.13.2 to 2.13.3.
    Difference
    0.1%
    Check dated 2024-12-14T23:16:46.000Z thumbnail image
  7. Check
    44 days ago
    Change Detected
    Summary
    The website has updated the contact details section for the study, now providing information on who to contact for questions about joining the study and where it is taking place, while removing the previous wording about the study conductors.
    Difference
    2%
    Check dated 2024-12-07T18:57:20.000Z thumbnail image
  8. Check
    58 days ago
    Change Detected
    Summary
    Several key URLs related to genetics, diagnostic imaging, and clinical trials have been removed, indicating a significant reduction in available resources on these topics.
    Difference
    3%
    Check dated 2024-11-23T05:36:15.000Z thumbnail image
  9. Check
    65 days ago
    Change Detected
    Summary
    New resources have been added, including links to MedlinePlus for genetics and lung cancer, as well as information on diagnostic imaging and medications like Ferumoxytol and Pembrolizumab.
    Difference
    0.4%
    Check dated 2024-11-16T01:22:55.000Z thumbnail image

Stay in the know with updates to Pembrolizumab+Ferumoxytol MRI in NSCLC Brain Metastases Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab+Ferumoxytol MRI in NSCLC Brain Metastases Clinical Trial page.